66
Participants
Start Date
December 31, 2003
Primary Completion Date
July 31, 2007
Study Completion Date
September 30, 2008
bortezomib
Memorial Sloan-Kettering Cancer Center, New York
Emory Winship Cancer Institute, Atlanta
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Roswell Park Cancer Institute, Buffalo
Collaborators (1)
Beth Israel Deaconess Medical Center
OTHER
Massachusetts General Hospital
OTHER
Brigham and Women's Hospital
OTHER
Roswell Park Cancer Institute
OTHER
Emory University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Millennium Pharmaceuticals, Inc.
INDUSTRY
Dana-Farber Cancer Institute
OTHER